HNB Home · Heated Tobacco and Vaping Industry NewsChinese website
Home Vaping News Foreign Doctors Begin Studying Nicotine Patches for COVID-19 Treatment
Vaping News · nicotine

Foreign Doctors Begin Studying Nicotine Patches for COVID-19 Treatment

According to Vaping Post, data from around the world continues to suggest that smoking, or more precisely nicotine consumption, may be a protective factor against coronavirus infection, and doctors in Wales are studying nicotine patches as a possible trea
According to Vaping Post, data from around the world increasingly suggests that smoking, or more precisely, nicotine consumption, may be a protective factor against contracting the coronavirus, and doctors in Wales are studying the use of nicotine patches as a potential treatment.<\/span><\/div>
 <\/div>
Foreign doctors begin studying nicotine patches for COVID-19 treatment.<\/span><\/div>
 <\/div>
It is well known that smoking leads to excessive respiratory diseases, cancers, and other illnesses. Therefore, as COVID-19 began to spread, health authorities naturally assumed that smokers were at a higher risk of contracting the virus and would exhibit more severe symptoms than most. However, to many people's surprise, contrary evidence began to emerge.<\/span><\/div>
 <\/div>
Data from around the world began to suggest that smoking seems to be a protective factor against contracting the virus. A prominent doctor in Wales believes that nicotine patches could be a treatment for the coronavirus. Dr. Jonathan Davis, an orthopedic consultant at Royal Glamorgan Hospital, stated that this “powerful” drug has the potential to block the virus from entering cells.<\/span><\/div>
 <\/div>
Foreign doctors begin studying nicotine patches for COVID-19 treatment.<\/span><\/div>
 <\/div>
The study was published in the British Medical Journal (BMJ) and is currently under review by French scientists, who are also conducting a study aimed at determining the possible correlation between daily smoking and susceptibility to SARS-CoV-2 infection.<\/span><\/div>
 <\/div>
Research conducted in France indicates that the daily smoking rate among COVID-19 patients is 5.3%, while the daily smoking rate in the French population is 25.4%. These findings led researchers to conclude that daily smokers are significantly less likely to exhibit symptoms or severe SARS-CoV-2 infections compared to the general population.<\/span><\/div>
 <\/div>
“The idea behind the French study is to understand COVID-19 as attaching to the receptors on the upper respiratory tract cells (known as ACE 2 receptors). The virus then unlocks the cells like a key, allowing it to enter and use the cell's infrastructure to replicate,” Davis explained.<\/span><\/div>
 <\/div>
“While nicotine can also attach to these receptors, acting as a key to open the cells, it does not actually enter. The French research team hypothesized that, on the contrary, it acts as a barrier to the virus entering the cells, so to speak, because the key is already in the lock.”<\/span><\/div>
 <\/div>
At the same time, Davis added that, of course, it is always a good idea for smokers to quit. He stated: “A study published in the New England Journal of Medicine shows that smokers are less likely to contract the coronavirus, but if they do contract it, there is substantial evidence that they may be more severely affected.”<\/span><\/div>
 <\/div>
“I want to emphasize that the overwhelming majority of evidence suggests that smokers should quit immediately, but they are better off using nicotine patches to gradually reduce their nicotine levels to avoid the effects of sudden withdrawal, which theoretically could be the best way to quit. If they are infected with the coronavirus at that time, it could exacerbate the infection.”<\/span><\/div>
H
HNB Editorial Team

HNB Home focuses on heated tobacco and vaping industry coverage, including product reviews, brand information, and global market updates.